CAR T/NK cell therapy for AML relapsed after allo HCT | Naoki Hosen, MD, PhD

Naoki Hosen, MD, PhD
Professor
University of Osaka Graduate School of Medicine

JOIN HERE!

Dr. Hosen’s objectives:

• Analyze CAR T/NK cell therapy for AML relapsed after allo HCT

FACULTY DISCLOSURE:

Dr. Hosen has indicated the following financial relationships with commercial interests:

Grant or research support | Otsuka Pharmaceutical

Planning Committee Disclosure

Dr. Lekakis has indicated that he has no relevant financial relationships with commercial interests.

Target Audience

Faculty, Primary Care Physicians, APRNs, PharmD

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.